15000/Boxes
Canmab 440mg Injection contains trastuzumab and is used to treat HER2-positive breast cancer. It interferes with HER2 receptors on cancer cells, hindering their growth and division.
Canmab Injection Features:
• Targeted therapy for HER2-positive breast cancer.
• Administered through intravenous infusion under medical supervision.
• Combined with other treatments for comprehensive cancer care.
• Requires vigilant monitoring for potential side effects.
Minimum Order | 1 |
Copyright © 2024 Shivrupesh Pharma Private Limited All Rights Reserved.